Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Symptoms, Doctors, Treatments, Advances & More

Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism Overview

Save information for later
Sign Up

Learn About Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism

View Main Condition: Cardiomyopathy

What is the definition of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism?
Dilated cardiomyopathy with hypergonadotropic hypogonadism (DCMHH) is a condition that primarily affects the heart and gonads (male testes or female ovaries). It is characterized by a disease of the heart muscle (dilated cardiomyopathy) and little or no production of sex hormones due to a problem with the pituitary gland or hypothalamus (hypergonadotropic hypogonadism). Other symptoms might include: characteristic facial features, intellectual disability, mild skeletal anomalies, and abnormalities of the metabolic system. Some cases of DCMHH are caused by genetic changes in the LMNA gene. Both autosomal dominant and autosomal recessive inheritance patterns have been described.
What are the alternative names for Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism?
  • Dilated cardiomyopathy with hypergonadotropic hypogonadism
  • Cardiogenital syndrome
  • Dilated cardiomyopathy-hypergonadotropic hypogonadism syndrome
  • Genital anomaly with cardiomyopathy
  • Malouf syndrome
  • Najjar syndrome
Who are the top Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism Local Doctors?
Elite in Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Volker Debus
Elite in Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Volker Debus
Muenster, NW, DE 

Volker Debus practices in Muenster, Germany. Mr. Debus is rated as an Elite expert by MediFind in the treatment of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism. His top areas of expertise are Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism, PGM1-CDG, Cardiomyopathy Hypogonadism Metabolic Anomalies, and Ventricular Fibrillation.

Elite in Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Thorsten Marquardt
Elite in Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Thorsten Marquardt
Albert Schweitzer Str. 33, 
Muenster, NW, DE 

Thorsten Marquardt practices in Muenster, Germany. Mr. Marquardt is rated as an Elite expert by MediFind in the treatment of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism. His top areas of expertise are Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism, PGM1-CDG, Niemann-Pick Disease, Glutaric Acidemia Type 2, and Thrombectomy.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Monique Piraud
Elite in Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism
Monique Piraud
Service De Biochimie Et Biologie Moléculaire Grand Est, Erythrocytaires Et Dépistage Périnatal, Centre De Biologie Et De Pathologie Est, 
Lyon, FR 

Monique Piraud practices in Lyon, France. Ms. Piraud is rated as an Elite expert by MediFind in the treatment of Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism. Her top areas of expertise are Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism, Sialuria, Sialic Acid Storage Disease, and Fucosidosis.

View All Doctors
What are the latest Dilated Cardiomyopathy with Hypergonadotropic Hypogonadism Clinical Trials?
Coordination of Rare Diseases at Sanford
Coordination of Rare Diseases at Sanford
Enrollment Status: Recruiting
Publish Date: May 29, 2025

Summary: CoRDS, or the Coordination of Rare Diseases at Sanford, is based at Sanford Research in Sioux Falls, South Dakota. It provides researchers with a centralized, international patient registry for all rare diseases. This program allows patients and researchers to connect as easily as possible to help advance treatments and cures for rare diseases. The CoRDS team works with patient advocacy groups, in...

Match to trials
Find the right clinical trials for you in under a minute
Get started
View All Clinical Trials
Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center